Barinthus Biotherapeutics plc

Barinthus Biotherapeutics plc

BRNS
Barinthus Biotherapeutics plcUS flagNASDAQ Global Market
0.74
USD
-0.02
- -
30.23MMarket Cap

Income Statement (USD)

2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Sales/Revenue/Turnover
- -
5
- -
45
1
15
- -
+ Sales & Services Revenue
- -
5
- -
45
1
15
- -
- Cost of Revenue
- -
- -
- -
- -
- -
- -
- -
+ Cost of Goods & Services
- -
- -
- -
- -
- -
- -
- -
Gross Profit
- -
- -
- -
- -
- -
- -
- -
+ Other Operating Income
- -
-5
- -
-45
-1
-15
- -
- Operating Expenses
- -
22
41
48
81
67
64
+ Selling, General & Admin
- -
10
25
6
40
30
41
+ Research & Development
- -
11
16
41
41
38
24
+ Other Operating Expense
- -
- -
- -
- -
- -
-1
-1
Operating Income (Loss)
- -
-17
-41
-3
-80
-52
-64
- Non-Operating (Income) Loss
- -
1
10
-4
-4
9
3
+ Interest Expense, Net
- -
4
3
-3
-3
-3
-2
+ Interest Expense
- -
4
3
- -
- -
- -
- -
- Interest Income
- -
- -
- -
3
3
3
2
+ Other Non-Op (Income) Loss
- -
-3
7
-1
-1
12
5
Pretax Income
- -
-18
-51
1
-77
-61
-67
- Income Tax Expense (Benefit)
- -
- -
- -
-4
-3
- -
- -
- (Income) Loss from Affiliates
- -
- -
- -
- -
- -
- -
- -
Income (Loss) from Cont Ops
- -
-18
-51
5
-73
-61
-66
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
- -
- -
- -
Income (Loss) Incl. MI
- -
-17
-51
5
-73
-61
-66
- Minority Interest
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
- -
-18
-51
5
-73
-61
-66
- Preferred Dividends
- -
- -
- -
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
- -
- -
- -
Net Income Avail to Common, GAAP
- -
-18
-51
5
-73
-61
-66
EBIT
- -
-17
-41
-3
-80
-52
-64
EBITDA
- -
-17
-41
2
-75
-46
-58
EBITDA Margin (%)
- -
-343.48
-15,155.97
3.4
-9,354.61
-307.15
- -
EBITA
- -
-17
-41
-3
-80
-52
-64
Gross Margin (%)
- -
100
100
100
100
100
- -
Operating Margin (%)
- -
-347.79
-15,380.6
-6.27
-10,031.55
-345.9
- -
Profit Margin (%)
- -
-367.27
-18,979.48
11.95
-9,145.51
-408
- -
Sales per Employee
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
1
4
5
6
6
Basic Weighted Avg Shares
- -
- -
26
37
38
39
41
Basic EPS, GAAP
- -
-371.62
-1.96
0.14
-1.91
-1.55
-1.64
Basic EPS from Cont Ops
- -
-376.38
-1.97
0.14
-1.91
-1.55
-1.64
Diluted Weighted Avg Shares
- -
- -
26
38
38
39
41
Diluted EPS, GAAP
- -
-371.62
-1.96
0.14
-1.91
-1.55
-1.64
Diluted EPS from Cont Ops
- -
-376.38
-1.97
0.14
-1.91
-1.55
-1.64

Balance Sheet (USD)

2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Total Current Assets
16
48
227
213
157
126
78
+ Cash, Cash Equivalents & STI
11
43
214
194
142
111
70
+ Cash & Cash Equivalents
11
43
214
194
142
111
70
+ ST Investments
- -
- -
- -
- -
- -
- -
- -
+ Accounts & Notes Receiv
4
5
12
18
13
7
1
+ Accounts Receivable, Net
1
1
- -
6
- -
- -
- -
+ Notes Receivable, Net
- -
- -
- -
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
- -
- -
- -
+ Other Receivable, Net
3
4
12
12
13
7
1
+ Inventories
- -
- -
- -
- -
- -
- -
- -
+ Raw Materials
- -
- -
- -
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
- -
- -
- -
+ Other ST Assets
1
- -
1
1
1
8
6
+ Misc ST Assets
- -
- -
- -
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
Total Noncurrent Assets
3
3
54
57
58
35
20
+ Property, Plant & Equip, Net
3
3
9
16
19
12
5
+ Property, Plant & Equip
3
3
10
17
23
21
13
- Accumulated Depreciation
- -
- -
1
1
4
9
8
+ LT Investments & Receivables
- -
- -
- -
- -
- -
- -
- -
+ LT Investments
- -
- -
- -
- -
- -
- -
- -
+ LT Receivables
- -
- -
- -
- -
- -
- -
- -
+ Other LT Assets
- -
- -
45
41
38
23
15
+ Total Intangible Assets
- -
- -
44
40
37
22
14
+ Goodwill
- -
- -
13
12
12
- -
- -
+ Other Intangible Assets
- -
- -
31
28
25
22
14
+ LT Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Assets
- -
- -
1
1
1
1
1
Total Assets
19
51
281
270
215
160
98
+ Payables & Accruals
5
6
9
10
8
10
7
+ Accounts Payable
4
5
2
4
2
2
- -
+ Accrued Taxes
- -
- -
- -
- -
- -
2
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
- -
- -
- -
+ Other Payables & Accruals
1
2
6
6
7
5
6
+ ST Debt
- -
- -
1
- -
2
2
2
+ ST Borrowings
- -
- -
- -
- -
- -
- -
- -
+ ST Finance Leases
- -
- -
1
- -
2
2
2
+ Other ST Liabilities
1
1
2
2
2
4
1
+ Deferred Revenue
- -
- -
- -
- -
- -
2
1
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
+ Misc ST Liabilities
- -
1
1
2
2
2
- -
Total Current Liabilities
6
8
11
12
13
16
10
+ LT Debt
2
46
7
8
11
10
9
+ LT Borrowings
- -
45
- -
- -
- -
- -
- -
+ LT Finance Leases
2
1
7
8
11
10
9
+ Other LT Liabilities
34
34
10
6
4
4
5
+ Accrued Liabilities
- -
- -
8
4
1
- -
- -
+ Pension Liabilities
- -
- -
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Liabilities
34
34
2
3
3
4
4
Total Noncurrent Liabilities
35
80
17
15
15
15
14
Total Liabilities
41
88
28
27
28
30
24
+ Preferred Equity and Hybrid Capital
- -
- -
- -
- -
- -
- -
- -
+ Share Capital & APIC
16
22
369
380
387
393
394
+ Common Stock
- -
- -
- -
- -
- -
- -
- -
+ Additional Paid in Capital
16
22
369
380
387
393
394
- Treasury Stock
- -
- -
- -
- -
- -
- -
- -
+ Retained Earnings
-38
-58
-109
-103
-177
-238
-304
+ Other Equity
- -
-1
-8
-33
-23
-26
-16
Equity Before Minority Interest
-22
-37
252
243
187
130
74
+ Minority/Non Controlling Interest
- -
- -
- -
- -
- -
- -
- -
Total Equity
-22
-37
253
243
187
130
74
Total Liabilities & Equity
19
51
281
270
215
160
98
Shares Outstanding
34
34
37
38
39
40
41
Number of Employees
- -
- -
- -
- -
- -
- -
- -
Capital Leases - Total
2
2
7
9
13
12
11
Net Debt
-11
1
-214
-194
-142
-111
-70
Net Debt to Equity
51.78
-3.88
-84.69
-79.93
-75.99
-85.04
-94.84
Tangible Common Equity Ratio
-117.87
-73.63
87.92
88.11
84.35
78.11
71.43
Current Ratio
2.83
6.27
20.32
17.4
12.45
8.03
7.77
Cash Conversion Cycle
- -
- -
- -
- -
- -
- -
- -

Cash Flow Statement (USD)

2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
+ Net Income
- -
-18
-51
5
-73
-61
-66
+ Depreciation & Amortization
- -
- -
1
4
5
6
6
+ Non-Cash Items
- -
5
25
-19
11
24
13
+ Stock-Based Compensation
- -
4
16
10
5
5
- -
+ Deferred Income Taxes
- -
- -
- -
-4
-3
- -
- -
+ Asset Impairment Charge
- -
- -
- -
- -
- -
17
6
+ Other Non-Cash Adj
- -
1
9
-24
9
2
7
+ Chg in Non-Cash Work Cap
- -
2
-7
-6
6
3
- -
+ (Inc) Dec in Accts Receiv
- -
1
-3
-5
6
-2
6
+ (Inc) Dec in Inventories
- -
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Prepaid Assets
- -
- -
-4
-2
2
4
2
+ Inc (Dec) in Accts Payable
- -
2
1
2
-1
1
-6
+ Inc (Dec) in Other
- -
- -
-1
-1
- -
- -
-2
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
Cash from Operating Activities
- -
-11
-33
-14
-51
-29
-48
+ Change in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
+ Acq of Fixed & Intang
- -
- -
-1
-6
-5
-1
- -
+ Acq of Fixed Prod Assets
- -
- -
-1
-6
-5
-1
- -
+ Acq of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
+ Cash (Repurchase) of Equity
- -
- -
103
- -
2
2
- -
+ Increase in Capital Stock
- -
- -
103
- -
2
2
- -
+ Decrease in Capital Stock
- -
- -
- -
- -
- -
- -
- -
+ Net Change in LT Investment
- -
- -
- -
- -
- -
- -
- -
+ Dec in LT Investment
- -
- -
- -
- -
- -
- -
- -
+ Inc in LT Investment
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Acq & Div
- -
- -
-12
- -
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
-12
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
Cash from Investing Activities
- -
- -
-13
-6
-5
-1
- -
+ Dividends Paid
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Debt
- -
41
- -
- -
- -
- -
- -
+ Cash From Debt
- -
41
- -
- -
- -
- -
- -
+ Repayments of Debt
- -
- -
- -
- -
- -
- -
- -
+ Other Financing Activities
- -
- -
120
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
Cash from Financing Activities
- -
41
223
- -
2
2
- -
Effect of Foreign Exchange Rates
- -
2
-6
- -
2
-2
7
Net Changes in Cash
- -
30
177
-20
-54
-28
-48
EBITDA
- -
-17
-41
2
-75
-46
-58
EBITDA Margin (%)
- -
-343.48
-15,155.97
3.4
-9,354.61
-307.15
- -
Free Cash Flow
- -
-11
-34
-21
-56
-30
-48
Net Cash Paid for Acquisitions
- -
- -
12
- -
- -
- -
- -
Free Cash Flow to Firm
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Equity
- -
30
-34
-20
-56
-30
-48
Free Cash Flow per Basic Share
- -
-237.61
-1.3
-0.55
-1.47
-0.76
-1.18
Price/Free Cash Flow
- -
- -
-9.15
-10.82
-3.11
-1.7
-0.59
Cash Flow to Net Income
- -
0.62
0.64
-2.7
0.69
0.47
0.72
Capital Expenditures
- -
- -
-1
-6
-5
-1
- -